High prognostic significance of residual disease after neoadjuvant chemotherapy:: a retrospective study in 710 patients with operable breast cancer (vol 94, pg 255, 2005)

被引:1
作者
Abrial, Sophie Catherine
Penault-Llorca, Frederique
Delva, Remi
Bougnoux, Philippe
Leduc, Bernard
Mouret-Reynier, Marie-Ange
Mery-Mignard, Dominique
Bleuse, Jean-Pierre
Dauplat, Jacques
Cure, Herve
Chollet, Philippe
机构
[1] Ctr Jean Perrin, Bur Rech Clin, F-63011 Clermont Ferrand 1, France
[2] INSERM, U484, F-63005 Clermont Ferrand, France
[3] Ctr Paul Papin, F-49036 Angers, France
[4] CHU Tours, Hop Bretonneau, F-37044 Tours 1, France
[5] Ctr Hosp Gen, F-19312 Brive La Gaillarde, France
[6] Sanofi Aventis, F-94255 Gentilly, France
关键词
D O I
10.1007/s10549-006-9237-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:365 / 365
页数:1
相关论文
共 1 条
[1]   High prognostic significance of residual disease after neoadjuvant chemotherapy:: a retrospective study in 710 patients with operable breast cancer [J].
Amat, S ;
Abrial, C ;
Penault-Llorca, F ;
Delva, R ;
Bougnoux, P ;
Leduc, B ;
Mouret-Reynier, MA ;
Mery-Mignard, D ;
Bleuse, JP ;
Dauplat, J ;
Curé, H ;
Chollet, P .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (03) :255-263